Prothena Announces Executive Appointments
As Chief Strategy Officer and Chief Financial Officer,
“Over the past year, we have made tremendous progress growing our pipeline with programs at every stage of development to facilitate our transition to a fully integrated research, development and commercial biotechnology company. These management enhancements best position us to leverage our momentum and set the company up for long-term growth and success,” said
“It is more important than ever for biotechnology companies to successfully transform from innovation hubs to well-positioned enterprises focused on long-term growth,” said
“Our employees’ ability to drive groundbreaking innovation for some of the most devastating diseases affecting society today is inspiring.
Media & Investors:
Source: Prothena Corporation plc